P J Connelly

Summary

Country: UK

Publications

  1. ncbi request reprint Current smoking and response to cholinesterase inhibitor therapy in Alzheimer's disease
    Peter J Connelly
    Department of Psychiatry, University of Dundee, Murray Royal Hospital, Muirhall Road, Perth PH2 7BH, UK
    Dement Geriatr Cogn Disord 19:11-4. 2005
  2. doi request reprint Fifteen year comparison of antipsychotic use in people with dementia within hospital and nursing home settings: sequential cross-sectional study
    Peter J Connelly
    Department of Old Age Psychiatry, Murray Royal Hospital, Muirhall Road, Perth PH2 7BH, Scotland, UK
    Int J Geriatr Psychiatry 25:160-5. 2010
  3. ncbi request reprint A randomised double-blind placebo-controlled trial of folic acid supplementation of cholinesterase inhibitors in Alzheimer's disease
    Peter J Connelly
    Department of Psychiatry, University of Dundee, Murray Royal Hospital, Perth, UK
    Int J Geriatr Psychiatry 23:155-60. 2008
  4. ncbi request reprint SIGN guideline for the management of patients with dementia
    Peter J Connelly
    Department of Psychiatry, University of Dundee, Murray Royal Hospital, Perth, UK
    Int J Geriatr Psychiatry 21:14-6. 2006
  5. ncbi request reprint Hypertension, white matter change and response to cholinesterase inhibitors in Alzheimer's disease
    Peter J Connelly
    Department of Psychiatry, University of Dundee, Murray Royal Hospital, Perth, UK
    Int J Geriatr Psychiatry 20:623-8. 2005
  6. pmc Predicting the outcome of cholinesterase inhibitor treatment in Alzheimer's disease
    P J Connelly
    Department of Psychiatry, University of Dundee, Murray Royal Hospital, Muirhall Road, Perth, PH2 7BH, UK
    J Neurol Neurosurg Psychiatry 76:320-4. 2005
  7. ncbi request reprint Association of a salivary acetylcholinesterase with Alzheimer's disease and response to cholinesterase inhibitors
    Rachel Sayer
    Dundee Alzheimer s Disease Research Centre, Department of Psychiatry, University of Dundee Medical School, Ninewells Hospital, Dundee DD1 9SY, UK
    Clin Biochem 37:98-104. 2004
  8. ncbi request reprint Investigating and treating dementia in primary care
    Peter J Connelly
    Murray Road Hospital, Perth
    Practitioner 251:27-8, 30-1, 33 passim. 2007
  9. ncbi request reprint The treatment of mild Alzheimer's disease post-NICE
    Peter J Connelly
    Int J Geriatr Psychiatry 22:1262-3. 2007
  10. ncbi request reprint Memantine (Ebixa) in the later stages of dementia
    David J Findlay
    Department of Old Age Psychiatry, Royal Dundee Liff Hospital, Dundee DD2 5NF
    Hosp Med 64:654-7. 2003

Collaborators

  • Rachel Sayer
  • David J Findlay
  • Emma Law
  • Kieran C Breen

Detail Information

Publications11

  1. ncbi request reprint Current smoking and response to cholinesterase inhibitor therapy in Alzheimer's disease
    Peter J Connelly
    Department of Psychiatry, University of Dundee, Murray Royal Hospital, Muirhall Road, Perth PH2 7BH, UK
    Dement Geriatr Cogn Disord 19:11-4. 2005
    ..In smokers, the lack of association between improvement in DSST scores and good response may be representative of inhibitory properties of cigarette smoke that are unrelated to nicotine...
  2. doi request reprint Fifteen year comparison of antipsychotic use in people with dementia within hospital and nursing home settings: sequential cross-sectional study
    Peter J Connelly
    Department of Old Age Psychiatry, Murray Royal Hospital, Muirhall Road, Perth PH2 7BH, Scotland, UK
    Int J Geriatr Psychiatry 25:160-5. 2010
    ..We assessed the relationship between behaviour, function and antipsychotic use in people with dementia in a long-stay psychiatric unit and designated elderly mentally ill (EMI) nursing homes over a 15-year period...
  3. ncbi request reprint A randomised double-blind placebo-controlled trial of folic acid supplementation of cholinesterase inhibitors in Alzheimer's disease
    Peter J Connelly
    Department of Psychiatry, University of Dundee, Murray Royal Hospital, Perth, UK
    Int J Geriatr Psychiatry 23:155-60. 2008
    ....
  4. ncbi request reprint SIGN guideline for the management of patients with dementia
    Peter J Connelly
    Department of Psychiatry, University of Dundee, Murray Royal Hospital, Perth, UK
    Int J Geriatr Psychiatry 21:14-6. 2006
  5. ncbi request reprint Hypertension, white matter change and response to cholinesterase inhibitors in Alzheimer's disease
    Peter J Connelly
    Department of Psychiatry, University of Dundee, Murray Royal Hospital, Perth, UK
    Int J Geriatr Psychiatry 20:623-8. 2005
    ..We investigated the effect of hypertension and white matter lesions (WML) on response...
  6. pmc Predicting the outcome of cholinesterase inhibitor treatment in Alzheimer's disease
    P J Connelly
    Department of Psychiatry, University of Dundee, Murray Royal Hospital, Muirhall Road, Perth, PH2 7BH, UK
    J Neurol Neurosurg Psychiatry 76:320-4. 2005
    ....
  7. ncbi request reprint Association of a salivary acetylcholinesterase with Alzheimer's disease and response to cholinesterase inhibitors
    Rachel Sayer
    Dundee Alzheimer s Disease Research Centre, Department of Psychiatry, University of Dundee Medical School, Ninewells Hospital, Dundee DD1 9SY, UK
    Clin Biochem 37:98-104. 2004
    ..The aim of the study was to investigate the expression levels of markers of cholinergic function in saliva, which is a readily accessible body fluid that can be obtained from subjects with minimal distress...
  8. ncbi request reprint Investigating and treating dementia in primary care
    Peter J Connelly
    Murray Road Hospital, Perth
    Practitioner 251:27-8, 30-1, 33 passim. 2007
  9. ncbi request reprint The treatment of mild Alzheimer's disease post-NICE
    Peter J Connelly
    Int J Geriatr Psychiatry 22:1262-3. 2007
  10. ncbi request reprint Memantine (Ebixa) in the later stages of dementia
    David J Findlay
    Department of Old Age Psychiatry, Royal Dundee Liff Hospital, Dundee DD2 5NF
    Hosp Med 64:654-7. 2003
    ..Benefits are seen in cognitive, functional and global measures in both outpatients and nursing home residents. Prospective health economic benefits have been reported...
  11. ncbi request reprint Treating the dementia of 'Iris' with a cholinesterase inhibitor
    Peter J Connelly
    Int J Geriatr Psychiatry 18:355-6. 2003